Bionor Pharma
Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.
Basic Information
- Category: biotechnology
- Website: http://www.bionorpharma.com/en/
Evidence and Sources
- Bionor Pharma — Wikipedia (reference)
Citation Guidance
Explore biotechnology profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Bionor Pharma.
- Canonical profile: https://brandsource.ai/brands/bionor-pharma
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/bionor-pharma/json-ld
- Citation profile API: https://brandsource.ai/api/brands/bionor-pharma/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Structured profile (64/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.
Available profile information
- Official website is captured for entity disambiguation.
- 1 supporting source linked.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.